Treatment For Metastatic Hormone Sensitive Prostate Cancer (M - HSPC)
AUAUniversity3 Okt 2019

Treatment For Metastatic Hormone Sensitive Prostate Cancer (M - HSPC)

Co-Host: Kelvin Moses, MD At the conclusion of these activities, participants will be able to: 1. Identify the active agents and their mechanism of action in the management of metastatic HSPC. 2. Describe the risks and benefits of treatment for metastatic HSPC. CME Available: auau.auanet.org/node/26063 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma

Avsnitt(434)

Populärt inom Utbildning

rss-bara-en-till-om-missbruk-medberoende-2
historiepodden-se
det-skaver
harrisons-dramatiska-historia
nu-blir-det-historia
allt-du-velat-veta
johannes-hansen-podcast
not-fanny-anymore
rss-viktmedicinpodden
roda-vita-rosen
rss-foraldramotet-bring-lagercrantz
sektledare
i-vantan-pa-katastrofen
sa-in-i-sjalen
rss-max-tant-med-max-villman
rss-sjalsligt-avkladd
alska-oss
rss-basta-livet
rss-om-vi-ska-vara-arliga
rikatillsammans-om-privatekonomi-rikedom-i-livet